Protective Effects Of<i> Rubus</I><i> Tereticaulis</I> Leaves Ethanol Extract on Rats With Ulcerative Colitis and Bio-Guided Isolation of Its Active Compounds: a Combined <i>in Silico</I>, <i>in Vitro</I> and <i>in Vivo</I> Study
| dc.contributor.author | Sen, Ali | |
| dc.contributor.author | Ozbeyli, Dilek | |
| dc.contributor.author | Terali, Kerem | |
| dc.contributor.author | Goger, Fatih | |
| dc.contributor.author | Yildirim, Aybeniz | |
| dc.contributor.author | Ertas, Busra | |
| dc.contributor.author | Sener, Goksel | |
| dc.date.accessioned | 2025-01-11T13:00:48Z | |
| dc.date.available | 2025-01-11T13:00:48Z | |
| dc.date.issued | 2023 | |
| dc.description | dogan, ahmet/0000-0003-0603-5100; Yildirim, Aybeniz/0000-0002-5801-4726; Sen, Ali/0000-0002-2144-5741; Ozbeyli, Dilek/0000-0002-4141-6913; Terali, Kerem/0000-0002-9964-6383; ERTAS, BUSRA/0000-0001-8374-1098; Sener, Goksel/0000-0001-7444-6193; Goger, Fatih/0000-0002-9665-0256 | en_US |
| dc.description.abstract | The aim of this study was to evaluate the therapeutic effect of active ethanol extract obtained from the leaves of Rubus tereticaulis (RTME) against colitis, and to purify major compounds from this extract by bioassay-directed isolation. Rats with colitis induced via intra-rectal acetic acid administration (5%, v/v) received RTME or sulfasalazine for three consecutive days. On day four, all rats were decapitated, and the colonic tissue samples were collected for macroscopic score, colon weight, reduced glutathione (GSH), myeloperoxidase (MPO), and malondialdehyde (MDA) analyses. The active compounds and chemical composition of RTME were determined by bio-guided isolation and LC-MS/MS, respectively. Compared to the colitis group, the rats treated with RTME displayed significantly lowered macroscopic scores and colon wet weights (p < 0.001). These effects were confirmed biochemically by a decrease in colonic MPO activity (p < 0.001), MDA levels (p < 0.001), and an increase in GSH levels (p < 0.001). Kaempferol-3-O-beta-D-glucuronide (RT1) and quercetin-3-O-beta-D-glucuronide (RT2) were found to be the major compounds of RTME, as evidenced by in vitro anti-inflammatory and antioxidant activity-guided isolation. Their anti-inflammatory/antioxidant activities were also predicted by docking simulations. Additionally, quinic acid, 5-caffeoylquinic acid, quercetin pentoside, quercetin glucoside, quercetin3-O-beta-D-glucuronide, kaempferol-3-O-beta-D-glucuronide, and kaempferol rutinoside were identified in RTME via using LC-MS/MS. RT2, along with other compounds, may be responsible for the observed protective action of RTME against colitis. This study represents the first report on the beneficial effects of RTME in an experimental model of colitis and highlights the potential future use of RTME as a natural alternative to alleviate colitis. | en_US |
| dc.description.sponsorship | Marmara University Scientific Research Projects Coordination Unit [SAG -K- 110117-0001] | en_US |
| dc.description.sponsorship | This work has been supported by Marmara University Scientific Research Projects Coordination Unit under grant number SAG -K- 110117-0001. | en_US |
| dc.description.sponsorship | RTME demonstrated significant bioactivity in both in vitro and in vivo assays. Therefore, in an attempt to reveal the compounds that were responsible for this behavior, we decided to perform bioassay‐directed fractionation and subsequent isolation. Firstly, RTMH, RTMC, RTMEA and RTMAE fractions were obtained by liquid–liquid extraction from RTME. Then, in vitro antioxidant and anti-inflammatory activities of these fractions as well as total phenol and flavonoid contents were evaluated. RTMEA with IC50 values 12.34 and 9.00 μg/mL against ABTS and DPPH radicals showed significant antioxidant activity when compared to other fractions (p < 0.05) (Table 2). Also, this fraction exhibited the highest anti-inflammatory activity against 5-lipoxygenase at concentration of 156 μg/mL (p < 0.05) (Table 2). In addition, RTMEA had the most significant (p < 0.05) amount of phenolic (63.30 mg/g) and flavonoid (12.76 mg/g) compared to the other fractions (Table 3). Based on these results, priority was given to the ethyl acetate fraction of RTME (RTMEA) for active compound isolation. Of the obtained 4 sub-fractions (F1–F6; F7–F15; F16–F27; F28–F42), the isolation process was continued with F7–F15, which showed the best activity. [DPPH radical and LOX inhibition rate at a concentration of 50 μg/mL: 50.50 and 19.77% (F1–F6), 82.86 and 96.05% (F7–F15), 82.03 and 72.01% (F16–F27), 82.03 and 76.02% (F28–F42), respectively]. Two flavonol glucuronides, kaempferol-3-O-β-D-glucuronide (RT1, 30.3 mg) and quercetin-3-O-β-D-glucuronide (RT2, 23.4 mg), were isolated as major compounds from the active F7–F15 sub-fraction of RTMEA (Fig. 1). All isolated compounds were analyzed by spectroscopic methods (UV, 1H NMR, and 13C NMR-APT), and the resulting data were compared with those reported in the literature. (Detailed spectral data is included in supporting information.)This work has been supported by Marmara University Scientific Research Projects Coordination Unit under grant number SAG-K-110117-0001. | |
| dc.description.sponsorship | RTMEA, (12.76 mg/g, 13C NMR-APT, 50.50, 63.30 mg/g, 82.03, 82.86, F16–F27, F28–F42, F7–F15); Marmara Üniversitesi, (SAG-K-110117-0001) | |
| dc.identifier.citation | 1 | |
| dc.identifier.doi | 10.1016/j.cbi.2022.110263 | |
| dc.identifier.issn | 0009-2797 | |
| dc.identifier.issn | 1872-7786 | |
| dc.identifier.scopus | 2-s2.0-85142319014 | |
| dc.identifier.uri | https://doi.org/10.1016/j.cbi.2022.110263 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14627/72 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Ireland Ltd | en_US |
| dc.relation.ispartof | Chemico-Biological Interactions | |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Antioxidant Activity | en_US |
| dc.subject | Anti-Inflammatory Activity | en_US |
| dc.subject | Colitis | en_US |
| dc.subject | Flavonoids | en_US |
| dc.subject | Rubus Tereticaulis | en_US |
| dc.title | Protective Effects Of<i> Rubus</I><i> Tereticaulis</I> Leaves Ethanol Extract on Rats With Ulcerative Colitis and Bio-Guided Isolation of Its Active Compounds: a Combined <i>in Silico</I>, <i>in Vitro</I> and <i>in Vivo</I> Study | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | dogan, ahmet/0000-0003-0603-5100 | |
| gdc.author.id | Yildirim, Aybeniz/0000-0002-5801-4726 | |
| gdc.author.id | Sen, Ali/0000-0002-2144-5741 | |
| gdc.author.id | Ozbeyli, Dilek/0000-0002-4141-6913 | |
| gdc.author.id | Terali, Kerem/0000-0002-9964-6383 | |
| gdc.author.id | ERTAS, BUSRA/0000-0001-8374-1098 | |
| gdc.author.id | Goger, Fatih/0000-0002-9665-0256 | |
| gdc.author.id | Şener, Göksel/0000-0001-7444-6193 | |
| gdc.author.scopusid | 55250649800 | |
| gdc.author.scopusid | 6504603410 | |
| gdc.author.scopusid | 55867022200 | |
| gdc.author.scopusid | 8926845400 | |
| gdc.author.scopusid | 57215874552 | |
| gdc.author.scopusid | 57196052987 | |
| gdc.author.scopusid | 23017859400 | |
| gdc.author.scopusid | 55662834600 | |
| gdc.author.wosid | yıldırım, aybeniz/GZG-3445-2022 | |
| gdc.author.wosid | Gögel, Fatih/HTR-3454-2023 | |
| gdc.author.wosid | Ozbeyli, Dilek/AAC-2498-2020 | |
| gdc.author.wosid | Ertas, Busra/IQS-8337-2023 | |
| gdc.author.wosid | dogan, ahmet/C-1547-2015 | |
| gdc.author.wosid | Terali, Kerem/Q-3270-2016 | |
| gdc.author.wosid | Bitis, Leyla/NRY-1164-2025 | |
| gdc.author.wosid | Sen, Ali/HZI-1758-2023 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.description.department | Fenerbahçe University | en_US |
| gdc.description.departmenttemp | [Sen, Ali; Yildirim, Aybeniz; Bitis, Leyla] Marmara Univ, Fac Pharm, Dept Pharmacognosy, TR-34854 Istanbul, Turkiye; [Ozbeyli, Dilek] Marmara Univ, Vocat Sch Hlth Serv, Dept Med Serv & Tech, Istanbul, Turkiye; [Terali, Kerem] Cyprus Int Univ, Fac Med, Dept Med Biochem, Nicosia 99258, Cyprus; [Goger, Fatih] Afyonkarahisar Hlth Sci Univ, Fac Pharm, Dept Pharmaceut Bot, Afyon, Turkiye; [Ertas, Busra] Marmara Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkiye; [Dogan, Ahmet] Marmara Univ, Fac Pharm, Dept Pharmaceut Bot, Istanbul, Turkiye; [Sener, Goksel] Fenerbahce Univ, Fac Pharm, Dept Pharmacol, TR-34758 Istanbul, Turkiye | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.volume | 369 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.openalex | W4309079912 | |
| gdc.identifier.pmid | 36375516 | |
| gdc.identifier.wos | WOS:000967045500001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.openalex.fwci | 1.1239 | |
| gdc.openalex.normalizedpercentile | 0.76 | |
| gdc.plumx.crossrefcites | 4 | |
| gdc.plumx.facebookshareslikecount | 125 | |
| gdc.plumx.mendeley | 17 | |
| gdc.plumx.scopuscites | 6 | |
| gdc.scopus.citedcount | 6 | |
| gdc.wos.citedcount | 4 | |
| relation.isAuthorOfPublication.latestForDiscovery | 68ac39be-51c5-4820-a6c9-0bef06348d93 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 5052e089-e75d-4aec-a280-6353973e4819 |
